Prosecution Insights
Last updated: October 04, 2026

UNIVERSITÄT BERN

Technology area: Biotechnology & Pharmaceuticals

9 pending office actions • 4 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (67%)
1
Medium (11%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (33%)
§112 only2 (22%)
Double-patenting + other1 (11%)
Multi-statute (no §101)3 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
44% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
5
Business / Other
56% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRIDGES, DONAVAN LEE 1 — —
KIM, YOUNG J 1 64.8% +18.1%
DIETZ, NOE ROBERT 1 0.0% +0.0%
WARD, AARON DUREL 1 — —
LEE, JIA-HAI 1 49.0% +47.0%
ILLING, CAITLIN NORINE 1 48.9% +37.7%
BREEN, KIMBERLY CATHERINE 1 23.8% +56.9%
JOHANNSEN, DIANA B 1 53.2% +42.8%
HA, JULIE 1 75.7% +44.0%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18705292 MICROFLUIDIC CELL CULTURING DEVICE BRIDGES, DONAVAN LEE —
18704678 JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT KIM, YOUNG J —
18700883 SLEEP-BASED DETECTION AND INTERVENTION SYSTEM DIETZ, NOE ROBERT —
18691491 MINOR SPLICEOSOME TARGETING COMPOSITIONS AND THEIR USE IN CANCER TREATMENT WARD, AARON DUREL —
18565545 3D PRINTING OF SOLID-STATE PHANTOMS ILLING, CAITLIN NORINE —
18561525 REDOX SENSITIVE CRALBP MUTANT PROTEINS BREEN, KIMBERLY CATHERINE —
18016601 PROGNOSTIC BIOMARKERS FOR CANCER JOHANNSEN, DIANA B —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18704678 JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT KIM, YOUNG J —
18545392 NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS LEE, JIA-HAI —
18565545 3D PRINTING OF SOLID-STATE PHANTOMS ILLING, CAITLIN NORINE —
18561525 REDOX SENSITIVE CRALBP MUTANT PROTEINS BREEN, KIMBERLY CATHERINE —
18016601 PROGNOSTIC BIOMARKERS FOR CANCER JOHANNSEN, DIANA B —
17633201 STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION HA, JULIE —

Top Art Units

Art UnitApps
1658 1
1657 1
1682 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18705292 MICROFLUIDIC CELL CULTURING DEVICE BRIDGES, DONAVAN LEE — §102§103§112 Non-Final OA — Pending Apr 26, 2024
18704678 JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT KIM, YOUNG J — §101§102§103§112 Non-Final OA — Pending Apr 25, 2024
18700883 SLEEP-BASED DETECTION AND INTERVENTION SYSTEM DIETZ, NOE ROBERT — §102§103§112 Non-Final OA — Pending Apr 12, 2024
18691491 MINOR SPLICEOSOME TARGETING COMPOSITIONS AND THEIR USE IN CANCER TREATMENT WARD, AARON DUREL — §101§102§103§112 Non-Final OA — Pending Mar 13, 2024
18545392 NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS LEE, JIA-HAI 1658 §102§103§112DP Final Rejection — Pending Dec 19, 2023
18565545 3D PRINTING OF SOLID-STATE PHANTOMS ILLING, CAITLIN NORINE — §103§112 Non-Final OA — Pending Nov 30, 2023
18561525 REDOX SENSITIVE CRALBP MUTANT PROTEINS BREEN, KIMBERLY CATHERINE 1657 §112 Final Rejection — Pending Nov 16, 2023
18016601 PROGNOSTIC BIOMARKERS FOR CANCER JOHANNSEN, DIANA B 1682 §101§103§112 Final Rejection — Pending Jan 17, 2023
17633201 STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION HA, JULIE 1654 §112 Final Rejection — Pending Feb 06, 2022

Managing UNIVERSITÄT BERN's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month